453 
Direct Relation between Monocyte Gene Expression, Circulating Count, and Apoptosis Resistance following Therapy Interruption: Increased Metallothionein Gene Expression Associated with Functional Resistance against Apoptotsis Induction
Andrea Raymond*1, M Giri1, E Papasavvas1, A Hancock1, A Mackiewicz1, B Thiel1, K Mounzer2, and L Montaner1
1Wistar Inst, Philadelphia, PA, US and 2Philadelphia Field Initiating Group for HIV Trials, PA, US
Background: Freshly recovered monocytes from patients
chronically infected with HIV-1 (viremic) exhibit an apoptotic signature in
which a variety of genes related to apoptosis, such as the metallothionein gene
(MT1), are differentially expressed and have been demonstrated to be associated
with resistance to apoptosis-induced cell death (AICD). It is unknown how
closely the observed in vivo
apoptosis gene signature relates to regulation of AICD during an acute viremic
episode associated with monocyte count changes in vivo or its relation to in
vitro gene regulation following infection of macrophages.
Methods: Using archived peripheral blood mononuclear
cells (PBMC) derived from whole blood of patients within a cohort undergoing
structured treatment interruption or from seronegative donors resistance to
AICD (cadmium [CdCl2]), as measured by caspase-3 activation in
T-cells and monocytes, we obtained monocyte vs CD4 T-cell counts and gene
expression at the initiation and during a 4-week therapy interruption interval.
Total RNA was isolated and amplified from CD14 monocytes or CD4 T cells. Gene
expression as determined by quantitative real-time polymerase chain reaction
(RT-PCR) was also compared between acute viral rebound (therapy interruption)
and chronic viremia. Additionally, in
vitro R5 HIV-1 infection monocyte-derived macrophages (MDM) from
seronegative donors was analyzed, assessed for in vitro gene modulation as compared to in vivo alteration, and directly tested role of genes in AICD by
SiRNA.
Results: Increased monocyte counts
following therapy interruption (p
<0.03; median at week 0 to 400 and at week 4 to 500; 25% difference) was
associated with viral rebound, a significant drop in CD4 T-cell count (p <0.05; 15% difference), increased
resistance to AICD in monocyte but not in CD4+ T cells, and
increased MT1 expression. MT1 expression
remained high before and after viral rebound and during chronic viremia in
contrast to other apoptosis related genes examined. MT1 expression was elevated following HIV-1
infection of macrophages in vitro and
its inhibition increased AICD following CdCl2 induction.
Conclusions: We identified that in vivo changes in monocyte count can be associated with regulation
of apoptosis and expression of MT1. This study shows a direct role for MT1
expression in resistance to induced apoptosis during HIV-1 infection in vitro and suggests a role for this
gene in maintenance of monocyte/macrophage cells in vivo during HIV-1 infection.
|